Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Trauma-related Wound: full-pipeline trial registry
A small indexed set (4 trials) with no open enrollment listed right now.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · none currently recruiting · #4,115 of 28,707 conditions by registered trial count
Trauma-related Wound: 4 US clinical trials tracked, none currently recruiting.
Trauma-related Wound is the subject of 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Stratatech, a Mallinckrodt Company, running 2 of these trials.
Enrollment posture brief
Registry condition trauma-related-wound
OPEN 0 | RECR 0% | LATE 1 | EARLY 1 | RANK #4115 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Trauma-related Wound has no open enrollment in this registry pull (4 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Trauma-related Wound on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Trauma-related Wound is recruiting below its size-band peers.
0 of 4 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Procellera® Compared to Standard of Care Treatment in Mitigating Biofilm Formation in Acute Trauma and Burn Wounds
The Metis Foundation
NCT04079998
StrataGraft® Skin Tissue as an Alternative to Autografting Deep Partial-Thickness Burns
Stratatech, a Mallinckrodt Company
NCT01437852
Post-Market Clinical Evaluation of the Spiracur SNaP Wound Care System for Treatment of Acute Trauma and Acute Surgical Excision Wounds
3M
NCT01417234
StrataGraft Safety, Tolerability and Efficacy in Pediatric Subjects
Stratatech, a Mallinckrodt Company
NCT05517902
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Trauma-related Wound records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Trauma-related Wound trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Trauma-related Wound page
4 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Trauma-related Wound trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Stratatech, a Mallinckrodt Company sponsors the most Trauma-related Wound trials on record, review their full trial history before evaluating a specific study. See Stratatech, a Mallinckrodt Company's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Trauma-related Wound condition card totals 4 registered trials; most-linked intervention StrataGraft; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.